Australian company Atmo Biosciences has received US FDA 510(k) clearance for its gas capsule system, meaning it can be marketed and sold in the country.
Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule
June 27, 2025 Australian Biotech
Latest Video
New Stories
-
The Dispatched 'Week in Review' Podcast - 27 June
June 27, 2025 - - Podcast -
Percheron licenses Phase 2 ready immuno-oncology candidate from Hummingbird
June 27, 2025 - - Australian Biotech -
PYC Therapeutics to present progress in Phelan-McDermid Syndrome at global congress
June 27, 2025 - - Australian Biotech -
Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule
June 27, 2025 - - Australian Biotech -
Hospital pharmacists use Rare Cancers Awareness Day to call for reform
June 27, 2025 - - Latest News -
MedAdvisor progressing review, including the potential sale of ANZ business
June 27, 2025 - - Latest News -
Mark Butler retains position on critical Cabinet committee
June 26, 2025 - - Latest News